| Product Code: ETC9969145 | Publication Date: Sep 2024 | Updated Date: Nov 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Dhaval Chaurasia | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
The United States witnessed a significant shift in its legalized cannabis medical import landscape in 2024, with top exporting countries including Switzerland, Ireland, India, Italy, and Singapore. Despite the negative Compound Annual Growth Rate (CAGR) from 2020 to 2024 at -4.13%, the industry experienced a sharp decline in growth rate from 2023 to 2024 at -38.1%. With a low Herfindahl-Hirschman Index (HHI) concentration in 2024, the market appears to be diversifying in terms of import sources, potentially signaling a more competitive and dynamic environment for medical cannabis imports in the US.

1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 United States (US) Legalized Cannabis Medical Market Overview |
3.1 United States (US) Country Macro Economic Indicators |
3.2 United States (US) Legalized Cannabis Medical Market Revenues & Volume, 2021 & 2031F |
3.3 United States (US) Legalized Cannabis Medical Market - Industry Life Cycle |
3.4 United States (US) Legalized Cannabis Medical Market - Porter's Five Forces |
3.5 United States (US) Legalized Cannabis Medical Market Revenues & Volume Share, By Product Type, 2021 & 2031F |
3.6 United States (US) Legalized Cannabis Medical Market Revenues & Volume Share, By Form, 2021 & 2031F |
3.7 United States (US) Legalized Cannabis Medical Market Revenues & Volume Share, By End Use, 2021 & 2031F |
3.8 United States (US) Legalized Cannabis Medical Market Revenues & Volume Share, By Compound, 2021 & 2031F |
4 United States (US) Legalized Cannabis Medical Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing acceptance and legalization of medical cannabis in more states |
4.2.2 Growing awareness of the potential health benefits of medical cannabis |
4.2.3 Rising demand for alternative treatment options for various medical conditions |
4.3 Market Restraints |
4.3.1 Stringent regulations and compliance requirements in the medical cannabis industry |
4.3.2 Limited availability of research and clinical trials on the efficacy of medical cannabis |
4.3.3 Challenges in insurance coverage and reimbursement for medical cannabis treatments |
5 United States (US) Legalized Cannabis Medical Market Trends |
6 United States (US) Legalized Cannabis Medical Market, By Types |
6.1 United States (US) Legalized Cannabis Medical Market, By Product Type |
6.1.1 Overview and Analysis |
6.1.2 United States (US) Legalized Cannabis Medical Market Revenues & Volume, By Product Type, 2021- 2031F |
6.1.3 United States (US) Legalized Cannabis Medical Market Revenues & Volume, By Cannabis Herb, 2021- 2031F |
6.1.4 United States (US) Legalized Cannabis Medical Market Revenues & Volume, By Cannabis Resin, 2021- 2031F |
6.2 United States (US) Legalized Cannabis Medical Market, By Form |
6.2.1 Overview and Analysis |
6.2.2 United States (US) Legalized Cannabis Medical Market Revenues & Volume, By Raw, 2021- 2031F |
6.2.3 United States (US) Legalized Cannabis Medical Market Revenues & Volume, By Processed, 2021- 2031F |
6.3 United States (US) Legalized Cannabis Medical Market, By End Use |
6.3.1 Overview and Analysis |
6.3.2 United States (US) Legalized Cannabis Medical Market Revenues & Volume, By Recreational, 2021- 2031F |
6.3.3 United States (US) Legalized Cannabis Medical Market Revenues & Volume, By Medicinal, 2021- 2031F |
6.4 United States (US) Legalized Cannabis Medical Market, By Compound |
6.4.1 Overview and Analysis |
6.4.2 United States (US) Legalized Cannabis Medical Market Revenues & Volume, By THC-Dominant, 2021- 2031F |
6.4.3 United States (US) Legalized Cannabis Medical Market Revenues & Volume, By CBD-Dominant, 2021- 2031F |
6.4.4 United States (US) Legalized Cannabis Medical Market Revenues & Volume, By Balanced THC & CBD, 2021- 2031F |
7 United States (US) Legalized Cannabis Medical Market Import-Export Trade Statistics |
7.1 United States (US) Legalized Cannabis Medical Market Export to Major Countries |
7.2 United States (US) Legalized Cannabis Medical Market Imports from Major Countries |
8 United States (US) Legalized Cannabis Medical Market Key Performance Indicators |
8.1 Number of states legalizing medical cannabis |
8.2 Patient enrollment in medical cannabis programs |
8.3 Number of medical professionals prescribing medical cannabis |
8.4 Investment in medical cannabis research and development |
8.5 Patient satisfaction and reported health outcomes from medical cannabis treatments |
9 United States (US) Legalized Cannabis Medical Market - Opportunity Assessment |
9.1 United States (US) Legalized Cannabis Medical Market Opportunity Assessment, By Product Type, 2021 & 2031F |
9.2 United States (US) Legalized Cannabis Medical Market Opportunity Assessment, By Form, 2021 & 2031F |
9.3 United States (US) Legalized Cannabis Medical Market Opportunity Assessment, By End Use, 2021 & 2031F |
9.4 United States (US) Legalized Cannabis Medical Market Opportunity Assessment, By Compound, 2021 & 2031F |
10 United States (US) Legalized Cannabis Medical Market - Competitive Landscape |
10.1 United States (US) Legalized Cannabis Medical Market Revenue Share, By Companies, 2024 |
10.2 United States (US) Legalized Cannabis Medical Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |